Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that.

Clinical Trial in Africa Finds Single-Dose Malaria Treatment Combining Four Existing Drugs as Effective as More Onerous Multi-Day, Multi-Dose Regimen Research advance from Gabon presented at the ...

ZURICH (Reuters) -Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies and very young children. Eight African ...

A drug approved to treat rare genetic diseases can also make human blood toxic to the mosquitoes that spread malaria, a new study finds. The drug, called nitisinone, is currently used to treat two ...

Coartem Baby, which was already approved for use in patients weighing over 11 pounds, contains artemether and lumefantrine that work together to fight the malaria parasite. HealthDay News — A new ...

Despite carrying the highest malaria burden in the world, Nigeria’s malaria treatment policies remain effective, according to ...

Researchers have observed effects of the common anti-malarial drug Artesunate on rats that suggest it may be an effective tool in treating hospital patients suffering from major trauma, according to ...

LONDON (Reuters) -A new antimalarial drug developed by Novartis is as effective as existing treatments and could help tackle rising drug resistance, the company said on Wednesday as it presented final ...

The federal government has launched a national initiative to protect the effectiveness of malaria treatments and prevent the emergence of drug resistance that could undermine decades of public health ...

Renato Aguilera, Ph.D., a professor of biological sciences at The University of Texas at El Paso, holds up a vial of pyronaridine, an anti-malarial drug that he recently patented for use in cancer ...